Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects

• Published in: European archives of psychiatry and clinical neuroscience Vol. 264; no. Suppl 1; pp. 83 - 90
• Main Authors: Franke, Andreas G., Bagusat, Christiana, Rust, Sebastian, Engel, Alice, Lieb, Klaus
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.11.2014; Springer Nature B.V
• Subjects: Central Nervous System Stimulants - pharmacology; Cognition - drug effects; Drug Users - statistics & numerical data; Ginkgo biloba; Humans; Medicine; Medicine & Public Health; Neurosciences; Nonprescription Drugs - pharmacology; Prescription Drugs - pharmacology; Prevalence; Psychiatry; Review; Substance-Related Disorders - epidemiology; Substance-Related Disorders - psychology; Stimulant(s); Prescriptive drug(s); Pharmacological cognitive enhancement; Over-the-counter-drug(s)

Pharmacological “cognitive enhancement” (CE) is defined as the use of any psychoactive drug with the purpose of enhancing cognition, e.g. regarding attention, concentration or memory by healthy subjects. Substances commonly used as CE drugs can be categorized into three groups of drugs: (1) over-the...